Current recommendations concerning PCI or CABG for multivessel coronary disease should be individualized and evidence-based. Important variables should be taken into consideration following the ...

For further information on how we select topics for development, please see our page about topic selection ...

Laura Niklason, M.D., Ph.D., Founder and CEO of Humacyte, expressed optimism about the transition to human clinical studies for the sdATEV in CABG. Over 400,000 CABG procedures are performed ...

The management of stable three-vessel coronary artery disease (CAD) remains a topic of ongoing debate, particularly concerning optimal treatment strategies for patients with normal ejection fraction.

Feb. 7, 2025 — Women who have experienced pregnancy complications have an increased risk of cardiovascular disease. Now, a new study shows that sisters of women with complicated pregnancies are ...

Blood vessel dysfunction in chronic diseases is worsened by the way specialised cells surround small blood vessels, latest evidence has highlighted. Otherwise known as perivascular cells, the ...

1 Eligible patients included those with a hemodynamically stable STEMI identified within 24 hours of symptom onset and found to have multivessel coronary artery disease (CAD) with at least one ...

Feb. 11, 2025 — Over 1,000 genes may serve as possible treatment targets for individuals with kidney disease, according to a new study. By creating the most complete and detailed genetic 'map ...

We apologize, but this video has failed to load. The study investigated the effects of Thykamine™ on liver disease progression in the widely used STAM mouse model of MASH/fibrosis at SMC Laboratories ...

Stents and coronary artery bypass grafting (CABG) treat blocked arteries and coronary artery disease (CAD). Stents are a less invasive option, while CABG is a major surgery. Your healthcare provider ...